Classification, Biomarkers, Traditional and Personalized Therapies
Natalia Nosalova,Mykhailo Huniadi,Ľubica Horňáková,Alexandra Valenčáková,Slavomir Horňák,Kamil Nagoos,Juraj Vozar,Dasa Cizkova
DOI: https://doi.org/10.3390/ijms25052891
IF: 5.6
2024-03-02
International Journal of Molecular Sciences
Abstract:In recent years, many studies have focused their attention on the dog as a proper animal model for human cancer. In dogs, mammary tumors develop spontaneously, involving a complex interplay between tumor cells and the immune system and revealing several molecular and clinical similarities to human breast cancer. In this review, we summarized the major features of canine mammary tumor, risk factors, and the most important biomarkers used for diagnosis and treatment. Traditional therapy of mammary tumors in dogs includes surgery, which is the first choice, followed by chemotherapy, radiotherapy, or hormonal therapy. However, these therapeutic strategies may not always be sufficient on their own; advancements in understanding cancer mechanisms and the development of innovative treatments offer hope for improved outcomes for oncologic patients. There is still a growing interest in the use of personalized medicine, which should play an irreplaceable role in the research not only in human cancer therapy, but also in veterinary oncology. Moreover, immunotherapy may represent a novel and promising therapeutic option in canine mammary cancers. The study of novel therapeutic approaches is essential for future research in both human and veterinary oncology.
biochemistry & molecular biology,chemistry, multidisciplinary